Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma

Reiji Fukano, Tetsuya Mori, Naoto Fujita, Ryoji Kobayashi, Tetsuo Mitsui, Koji Kato, Ritsuro Suzuki, Junji Suzumiya, Takahiro Fukuda, Motohiro Shindo, Nobuo Maseki, Tatsu Shimoyama, Keiko Okada, Masami Inoue, Jiro Inagaki, Yoshiko Hashii, Atsushi Sato, Ken Tabuchi

研究成果: Contribution to journalArticle

抄録

We report a retrospective analysis of 38 patients (age ≤ 30 years) who underwent allogeneic hematopoietic stem cell transplantation (allo-SCT) for relapsed or refractory anaplastic large-cell lymphoma (ALCL). Median follow-up for survivors after undergoing allo-SCT was 72 months (range, 35–96 months). Eight patients received reduced-intensity conditioning (RIC) regimens, including three patients with fludarabine plus melphalan-based regimens and five patients with fludarabine plus busulfan-based regimens. The remaining 30 patients received myeloablative conditioning (MAC) regimens. Median ages in the RIC and MAC groups were 24 and 15 years, respectively. The 5-year overall survival rates in the RIC and MAC groups were 100% and 49%, respectively (P = 0.018). The 5-year event-free survival rates in the RIC and MAC groups were 88% and 43%, respectively (P = 0.039). In the RIC group, four of the eight patients showed residual disease at allo-SCT, but all eight patients survived with complete remission (CR), including one patient with relapse. This result suggests that allo-SCT using the RIC regimen may be effective for relapsed or refractory ALCL in children, adolescents, and young adults, even in non-CR cases.

本文言語英語
ページ(範囲)723-728
ページ数6
ジャーナルInternational journal of hematology
110
6
DOI
出版ステータス出版済み - 12 1 2019

All Science Journal Classification (ASJC) codes

  • Hematology

フィンガープリント 「Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル